Codexis (CDXS) Debt Ratio (2017 - 2026)
Codexis (CDXS) posted quarterly Debt Ratio of 0.31 for Q1 2026, up 38.19% year-over-year from 0.23 in Q1 2025, and up 15.32% quarter-over-quarter from 0.27 in Q4 2025.
Codexis (CDXS) Debt Ratio (2017 - 2026) Analysis & Trends
Codexis' Debt Ratio history runs 5 years deep, the most recent figure standing at 0.31 for Q1 2026.
- In Q1 2026, Debt Ratio rose 38.19% year-over-year to 0.31; the TTM figure through Mar 2026 stood at 0.31 (up 38.19% YoY), while the FY2025 annual figure was 0.27, up 39.89% from the prior year.
- Debt Ratio for Q1 2026 stood at 0.31, up from 0.27 in the prior quarter.
- The five-year high for Debt Ratio was 0.32 in Q3 2025, with the low at 0.19 in Q1 2024.
- The 3-year median for Debt Ratio is 0.23 (2025), against an average of 0.25.
- Peak annual rise in Debt Ratio reached 65.88% in 2025, while the deepest fall reached 20.51% in 2025.
- Codexis' Debt Ratio stood at 0.19 in 2024, then surged by 39.89% to 0.27 in 2025, then advanced by 15.32% to 0.31 in 2026.
- Business Quant data shows CDXS's Debt Ratio at 0.31 in Q1 2026, 0.27 in Q4 2025, and 0.32 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.54 Bn | 130.69 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.89 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.84 Bn | 59.65 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.53 Bn | 51.39 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.47 |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn | 0.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.40 |
| Mar 31, 2026 | 0.31 |
| Dec 31, 2025 | 0.27 |
| Sep 30, 2025 | 0.32 |
| Jun 30, 2025 | 0.28 |
| Mar 31, 2025 | 0.23 |
| Dec 31, 2024 | 0.19 |
| Sep 30, 2024 | 0.19 |
| Jun 30, 2024 | 0.21 |
| Mar 31, 2024 | 0.19 |
| Sep 30, 2018 | 0.00 |
| Jun 30, 2018 | 0.00 |
| Mar 31, 2018 | 0.01 |
| Dec 31, 2017 | 0.01 |
| Sep 30, 2017 | 0.01 |
| Jun 30, 2017 | 0.01 |
| Mar 31, 2017 | 0.01 |